80 Nasdaq-Listed and Overseas Biopharma/MedTech Companies to Showcase at CHIPS Summit with 1,000+ One-on-One Meetings

The world is currently undergoing profound changes unseen in a century, and the pharmaceutical innovation market in China and globally is experiencing a significant transformation. In recent years, the landscape of China’s pharmaceutical market has changed dramatically. Under the impact of pharmaceutical policies and technological innovations, every link in the industry chain—including research and development, distribution, and marketing—is being redefined.

Each wave of technological revolution reshapes the business landscape, propelling companies with outstanding performance in technological innovation to rapid prominence. The United States, home to tens of thousands of innovative small and medium-sized medical enterprises and numerous high-tech medical firms listed on NASDAQ, stands as the most powerful source of medical technology innovation today, facing substantial capital and market demands.

According to a report by VCBeat Research Institute, China’s share of total financing in the new drug R&D sector has been steadily rising over the past five years. Currently, the domestic market still lacks substantial innovation, and there is significant demand in China’s healthcare market for overseas high-tech biopharmaceuticals and medical devices. We see emerging opportunities for investment in the healthcare industry.

VCBeat: Investment and Financing Data Report on the New Pharmaceutical Sector

"Looking globally, focusing on the future,"The 2nd Global Cross-Border Medical and Healthcare Industry Investment in China Summit — and Hangzhou Central Business District Economic Forum(hereinafter referred to as “CHIPS”) was launched in response. The conference will be held from October 16 to October 18, 2019, at the InterContinental Hangzhou. It is specially supported by the Hangzhou Municipal People’s Government, and hosted by the Hangzhou Investment Promotion Bureau (proposed), China Medical Investment Co., Ltd., and Legend Capital. Co-organizers include Galileo Global Group, THE MONEY CHANNEL, Buckman, Buckman & Reid, Inc., Hong Kong Weijian Pharmaceutical Group Co., Ltd., Hangzhou Phoenix Valley Equity Investment Co., Ltd., VCBeat, Leaguer Innovation, Qiantuhui, and DXY.cn (proposed). The event is undertaken by Hangzhou Xiacheng District State-owned Investment Holding Group Co., Ltd. and Zhejiang Phoenix Valley Healthcare Management Co., Ltd.

 VCBeat Channel Special Offer Ticket,Click the image or scan the QR code to register

In March last year, the inaugural CHIPS Summit, themed “Localization of Overseas Pharmaceutical Innovations in China,” was held at the InterContinental Hangzhou. The summit invited63 companiesListed biopharmaceutical and medical device companies on Nasdaq, European and American pharmaceutical enterprises, Russell Flannery, Editor-in-Chief of Forbes China, Zheng Hua, Chief Executive of Nasdaq China, and dozens of other industry heavyweights were in attendance, along with800 positionsIndustry professionals held a three-day conference.

This is the largest delegation of U.S. and European healthcare companies listed on Nasdaq to visit China for business matchmaking events in Chinese history., In addition, the forum innovatively established a one-on-one meeting session for Chinese and foreign enterprises and investors, and held600+ SessionsOne-on-one matchmaking sessions have significantly bridged the gap between enterprises and investors, fostering closer connections. These sessions have generated substantial influence within the industry and received widespread acclaim.

This CHIPS Summit will bring together global80 institutionsNasdaq-listed biopharmaceutical and medical device companies, along with pharmaceutical innovation enterprises from Europe and the United States, plan to invite heavyweight guests such as former FDA Commissioner Scott Gottlieb and He Ruyi, former Chief Scientist of the Center for Drug Evaluation (CDE), to attend an event featuring6 conference forums, over 80 overseas project roadshows, 800 one-on-one negotiation sessions, and a cocktail receptionetc.

Content Upgrade: Five new themed forums added, delivering high-value insights on trending topics.

This year’s CHIPS has undergone a comprehensive upgrade of its overall agenda. Compared to last year, which featured only one main venue, five new thematic forums will be added this year: the Clinical Trials Forum, the Pharmaceutical Digital Marketing Forum, the Medical Devices Forum, the Generic Drugs Forum, and the Innovative Drugs Forum. The conference will invite influential government officials, healthcare experts, industry leaders, and innovative entrepreneurs to share insights and exchange ideas through keynote reports, thematic speeches, and roundtable discussions.

Scale Upgrade: 80+ Overseas Projects, 800 Negotiation Sessions, Attracting 1,000 Industry Professionals

At the inaugural CHIPS Conference, 63 overseas projects were invited, primarily from the fields of chemical pharmaceuticals, biopharmaceuticals, and medical devices. Most of these projects are in Phase III clinical trials, with applications in oncology, immunology, hepatology, rare diseases, and ophthalmology.

Analysis of the First CHIPS Overseas Roadshow Projects

This year’s CHIPS has achieved comprehensive improvements in both the quantity and quality of projects. It is expected to invite 80+ high-quality overseas projects to attend for roadshows and conduct one-on-one negotiations with domestic investors. The confirmed list of participating projects is as follows:

(The list is continuously being updated...)

Format Upgrade: Conference + Roadshow + Cocktail Reception/Dinner for In-Depth, Multi-Dimensional Exchange

If you wish to gain insights into cutting-edge global trends, investment strategies from industry leaders, and the latest analytical perspectives, do not miss the main forums on October 16–17, along with themed sessions focused on pharmaceutical digital marketing, innovative drugs, generic drugs, clinical trials, and medical devices. For in-depth project collaboration and exchange, the one-on-one matchmaking sessions are an excellent choice; easily book your slots via the online platform to help you schedule your agenda efficiently on October 17–18. If you seek deeper engagement with distinguished guests, enjoy networking opportunities such as cocktail receptions, a Sino-foreign guest dinner, and a night cruise on West Lake, all designed to foster open dialogue in a relaxed and pleasant atmosphere.

A CHIPS Conference ticket represents more than just admission to a premier global summit on healthcare investment; it is a gateway to boundless opportunities. Whether you are an investor, an entrepreneur, or an industry professional focused on the development of global healthcare, you will find what you seek in this ticket.

Regarding tickets, VCBeat has secured special discounted tickets at prices lower than those on the official website.

All paid attendees are entitled to free access to the main conference and all parallel sessions, as well as overseas company roadshows and one-on-one networking sessions. The conference organizers will also provide you with lunch at the InterContinental Hotel for the three days of the summit.

The CHIPS official website currently offers two types of tickets: “Regular Tickets” and “Group Tickets.” Group ticket purchases are restricted to registrations from two or more individuals (inclusive) from the same company, and each company may schedule appointments with only one foreign enterprise per time slot. Currently, the most affordable early-bird group ticket available on the official website is priced at 4,000 yuan.

(Screenshot from the CHIPS official website)

VCBeat has been committed to building an efficient information exchange platform for venture capital and investment in the innovative healthcare industry. As a co-organizer of the CHIPS Conference, VCBeat has secured for its readersSpecial Discount Ticket, the regular ticket originally priced at 6,000 yuan is available exclusively through VCBeat’s registration channel3,280 yuan(Limited to 50 slots), regardless of whether they are from the same company, all can schedule a 1-on-1 consultation for overseas projects.

VCBeat Exclusive Deals Channel:http://www.huodongxing.com/event/1508406000300?qd=WZ01

(Scan the QR code for exclusive offers)